Your browser doesn't support javascript.
loading
Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study.
Mahil, Satveer K; Bechman, Katie; Raharja, Antony; Domingo-Vila, Clara; Baudry, David; Brown, Matthew A; Cope, Andrew P; Dasandi, Tejus; Graham, Carl; Khan, Hataf; Lechmere, Thomas; Malim, Michael H; Meynell, Freya; Pollock, Emily; Sychowska, Kamila; Barker, Jonathan N; Norton, Sam; Galloway, James B; Doores, Katie J; Tree, Timothy; Smith, Catherine H.
Afiliación
  • Mahil SK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Bechman K; St John's Institute of Dermatology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Raharja A; Centre for Rheumatic Diseases, King's College London, London, UK.
  • Domingo-Vila C; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Baudry D; Department of Immunobiology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Brown MA; St John's Institute of Dermatology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Cope AP; Centre for Rheumatic Diseases, King's College London, London, UK.
  • Dasandi T; Centre for Rheumatic Diseases, King's College London, London, UK.
  • Graham C; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Khan H; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Lechmere T; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Malim MH; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Meynell F; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Pollock E; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Sychowska K; Department of Immunobiology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Barker JN; Department of Immunobiology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Norton S; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Galloway JB; St John's Institute of Dermatology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Doores KJ; Psychology Department, Institute for Psychiatry Psychology and Neuroscience, King's College London, London, UK.
  • Tree T; Centre for Rheumatic Diseases, King's College London, London, UK.
  • Smith CH; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Lancet Rheumatol ; 4(1): e42-e52, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34778846

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Lancet Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Lancet Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido